Target intelligence / Profile preview

Adenine nucleotide translocator (ANT) (ANT)

Target
ANT
Molecular classification
Transporter, Mitochondrial carrier family, Solute carrier family 25
01

Overview

The Adenine nucleotide translocator (ANT), also known as the ADP/ATP carrier, is a vital transport protein located in the inner mitochondrial membrane. Its primary biological function is to facilitate the 1:1 exchange of mitochondrial ATP for cytosolic ADP, a process essential for maintaining the energy supply of the cell and supporting oxidative phosphorylation. Beyond its role in metabolism, ANT is a key component of the mitochondrial permeability transition pore (mPTP), making it a central regulator of apoptosis and cell death. In many cancers, the ANT2 isoform is overexpressed and acts as an anti-apoptotic factor, making it a promising target for pro-apoptotic anticancer therapies. Conversely, mutations in ANT1 are associated with various mitochondrial myopathies and ophthalmological disorders. Pharmacological modulation of ANT involves inhibitors like carboxyatractyloside and bongkrekic acid, which trap the transporter in specific conformational states, though many clinical drugs can also interact with ANT as an off-target, potentially leading to mitochondrial toxicity.

Other names
ADP/ATP carrierMitochondrial ADP/ATP translocaseSolute carrier family 25 member 4Solute carrier family 25 member 5Solute carrier family 25 member 6Solute carrier family 25 member 31AACANT1ANT2ANT3ANT4
02

Mechanism of action

Inhibition of the exchange of mitochondrial ATP for cytosolic ADP, modulation of the mitochondrial permeability transition pore (mPTP) to induce or inhibit apoptosis, and regulation of mitochondrial membrane potential.

03

Biological functions

ATP/ADP exchangeApoptosis regulationMitochondrial membrane permeabilizationOxidative phosphorylationMitophagy
04

Disease associations

CancerMitochondrial diseaseCardiovascular diseaseNeurodegenerative diseaseOphthalmological disease
05

Safety considerations

Mitochondrial toxicityCardiotoxicityLactic acidosisInterference with cellular energy homeostasis
06

Interacting drugs

Carboxyatractyloside

6 more in the full profile.

07

Biomarkers

ANT2 expression levelsMitochondrial membrane potential (ΔΨm)Cytochrome c release

Beyond the preview

Go deeper on Adenine nucleotide translocator (ANT) (ANT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenine nucleotide translocator (ANT) (ANT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call